Exostar's Identity Hubs - Making Security a Business Enabler Throughout the Drug Development Process
With a price tag north of $1B and a duration in the neighborhood of a decade, the drug development process costs too much and takes too long. That’s not news. In fact, pharmaceutical companies are in the midst of a sea change to a partner-centric business model to combat the problem.
For most organizations, the transition to working more closely with a variety of partners raises the priority of security to protect sensitive information and intellectual property. While protection is vital, it’s not the correct lens through which to view security. Protection should be a given.
Instead, pharmaceutical organizations should look to security as a business enabler. With the right security solution, collaboration with partners happens faster, more efficiently, and more effectively – without the threat of compromise. In that environment, the drug development process costs less and is completed sooner. Best of all, it opens the market availability to patent expiry window wider, bringing greater revenue and ROI to the business.
Exostar’s cloud-based Identity Hubs, which are delivered as-a-Service, speed partner onboarding and application integration, creating a trusted community. Individuals enjoy a seamless, single sign-on experience using their existing credentials, allowing them to increase productivity. Exostar’s Secure Access Manager (SAM) controls access to applications and information by enforcing the rules and privileges assigned by asset owners, so organizations can collaborate with confidence.
We’ve developed a newsletter that provides more detail on our Identity Hub concept, SAM, and how our Life Sciences Identity Hub is being leveraged by Merck to accelerate interactions with their partners while reducing their capital and operating expenditures. As a bonus, the newsletter also includes a recent Gartner report that predicts and explains how the security solutions market will evolve in 2015 and the years to come. Click here to download the newsletter and learn more about how Exostar can help you turn security from a cost center to a profit center and streamline the drug development process.
Total Page Views: 598
